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Summary
Objective: To evaluate the association between cigarette smoking and the subsequent development of osteoarthritis (OA) at four separate
sites: knee, hand, foot and cervical spine.
Methods: This cohort study examined 2505 men and women aged 40 years and older participating in the longitudinal Clearwater
Osteoarthritis Study (1988–current). Biennial physical exams, including serial radiographs, as well as historical information, were collected.
The Lawrence and Kellgren ordinal scale was used to determine radiological evidence of the study outcome, OA. Self-reported history
of smoking behavior was used to determine the study exposure. Smoking was classified using four approaches: (1) ever/never,
(2) former/never, (3) current/never, and (4) dose.
Results: Among the individuals at study entry, radiologically confirmed incident OA was detected during the follow-up period at four sites:
knee (32%), hand (49%), foot (28%), and cervical spine (52%). Approximately 11% were self-reported current smokers. Unadjusted analyses
indicated that individuals classified as current smokers demonstrated significant levels of protection from OA at all four sites investigated.
However, adjusted point estimates ranging from 0.60–1.48 were suggestive of no association between smoking and the development of OA
at any of the four sites investigated.
Conclusion: Based upon the findings of this prospective study, smoking does not appear to convey a clinically significant level of protection
against the development of radiologically-confirmed OA. While these findings corroborate previous studies indicating no association between
smoking and OA, anecdotal evidence warrants investigation into the role that cigarette smoking may play in the symptomatology of OA.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Osteoarthritis (OA) affects more than 21 million Americans
and is a leading cause of disability in the US1. Studies
within the past 10 years have suggested that cigarette
smoking may play a modestly protective role in the devel-
opment of OA. Four previous studies have examined
specifically the relationship smoking shares with OA2–5.
Conflicting results have been reported. While cigarette
smoking and its association with OA is largely unexplored,
past studies have reported point estimates spanning both
sides of the null value, ranging from 0.11 to 2.272. Perhaps
one of the earliest studies to investigate specifically the
OA-smoking relationship was conducted based upon an
unexpected finding of a modest, protective effect during
analysis of the first Health and Nutrition Examination Sur-
vey (HANES I)6. In 1989, Felson et al.3 further explored this
association using the Framingham Osteoarthritis Study
data. Results from their case-control study noted an
adjusted, protective influence on OA among heavy
smokers relative to never smokers (OR=0.81; P-value
<0.05)3. Subsequently, two case-control investigations29examined this relationship noting a similar protective influ-
ence. Hart and Spector reported protective effects in some
joint groups, while reporting cigarette smoking as a risk
factor for knee OA4. The current cohort investigation is
studying the hypothesis: among men and women aged
40 years and older, those individuals who smoke are no
more likely to develop OA (knee, hand, foot and cervical
spine) than are those individuals who do not smoke.Received 1 April 2002; revision accepted 17 September 2002.
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In 1988, the Arthritis Research Institute of America
(ARIA) located in Clearwater, Florida, initiated The
Clearwater Osteoarthritis Study (COS). The COS is an
on-going, prospective cohort study designed to identify
major risk factors for the development of OA, differentiate
risk factors for localized and generalized primary OA, as
well as to identify risk factors for the progression of OA.
Currently in its fifteenth year, the twenty-five year longi-
tudinal study collects demographic, historical, clinical, and
radiological data. ARIA is located appropriately in Pinellas
County, Florida drawing upon a population with a large
percentage of residents aged 65 years and older (22.5%)7.
The study sample of this older community comprises vol-
unteer participants who are recruited by various methods.
These include invitational letters, television and radio
announcements, newspaper articles publicizing the COS
30 F. V. Wilder et al.: Smoking and osteoarthritisstudy, articles posted in community organizations’ bulletins,
and seminars held at community clubs and organizations.
Males and female, aged 40 or older, are eligible for the
COS study. Individuals with and without radiographic OA
are eligible to enroll. To date, 3489 individuals have been
enrolled in the COS study, with less than 30 individuals
screened, but not subsequently enrolled. The following
study subjects were excluded from enrollment: individuals
with self-reported rheumatoid arthritis or variants (lupus
erythematosus, ankylosing spondylitis, etc.); gout; history
of methotrexate shots; disabling neuralgic disease; those
confined to a wheelchair; and lastly, those mentally
incompetent. Among the 3489 individuals that were
enrolled in the COS study, 984 were excluded from the
current analyses due to the following reasons: no follow-up
time recorded (N=859); incomplete data (N=26); and
individuals with prevalent OA at all four sites (N=99).
Accordingly, the current analyses evaluated 2505
individuals.
At initial contact with participants, a description of study
procedures was given, followed by a screening question-
naire, detailing inclusion and exclusion criteria. After
eligibility was determined and informed consent was
obtained, participants were asked to complete a self-
administered, mostly pre-coded form, the COS History
Questionnaire. This instrument collected detailed informa-
tion including demographics, family history, diet, occu-
pation, physical activity, injuries, and medical conditions. To
improve study follow-up, participants were asked the name,
the phone number, and address of a relative or a friend who
could provide location information in the event that institute
personnel were unable to contact the subject.
At the initial and all subsequent ARIA appointments, a
physical exam was conducted including X-rays. The COS
Physical Examination was completed at that time by the
institute clinicians. The physical examination had an
emphasis on clinical and functional joint evaluation. Height
and weight measurements were taken with the subjects
wearing stockings and indoor clothing. Study participants
were re-evaluated biennially, updating both the history
questionnaire and the clinical examination information.
For the purpose of this investigation, four distinct study
outcomes were defined: OA of the knee, hand, foot, and
cervical spine. Serial X-rays were taken initially at baseline
and subsequently every two years. A case was defined
when radiographic structural evidence of disease was
found. Each radiograph was graded 0 to 4 for OA by the
ordinal criteria of Kellgren and Lawrence8: 0, absent;
1, questionable osteophytes and no joint space narrowing;
2, definite osteophytes with possible joint space narrowing;
3, definite joint space narrowing with moderate multiple
osteophytes and some sclerosis; 4, severe joint space
narrowing with cysts, osteophytes and sclerosis present.
The c-spine radiograph view was lateral, and the knees
(weight bearing) hands and feet views were anterior-
posterior. Hand OA was defined as evidence of disease in
one or more of the hand joint sub-groups (right and left
second DIP, third PIP, and first CMC). Diagnosis of foot OA
was based on radiological evidence of disease in the
metatarso phalangeal joints. A licensed X-ray technician
using standard exposure techniques took X-rays, including
anterior weight-bearing knee radiographs. X-rays were
interpreted by a board-certified radiologist. Subjects whose
X-rays were interpreted as grades 0 or 1 were considered
disease-free for OA; subjects whose radiographs were
interpreted as grades 2, 3, or 4 were classified as cases. At
baseline, if an individual was free of OA at all four sites,they were included in each of the four smoking-OA studies:
hand, knee, foot, and spine. At baseline, if they were free
of, for example, hand and knee OA, they were included in
the hand and knee OA studies. In addition to examining
OA, severe radiographic OA (grades 3+) was considered
when investigating the relationship between smoking and
OA. To assess inter-reader validity, every tenth subject’s
assembled films were independently interpreted by a non-
affiliated radiologist who was blinded to the results of the
first reading. The study radiologist, as well as the indepen-
dent radiologist, was blinded to information about the
individual study participants.
Smoking, the study exposure, was originally defined
using four approaches: (1) ever/never, (2) former/never,
(3) current/never, and (4) dose: light, moderate, and heavy.
Differing methods of exposure quantification were utilized
in an attempt to adequately summarize the smoking history
of a given individual. The fourth method differentiated the
quantities of cigarettes smoked per day among current
smokers: light=1–19/day; moderate=20–39/day; and heavy=
40+/day. The factors included in the final analyses were
age at study entry, gender, body mass index (BMI), hered-
ity, physical activity level, high risk occupation, and OA
status at other sites. Heredity, a self-reported variable, was
defined as a participant having one or more, siblings or
parents who developed OA. Physical activity considered
participants’ both aerobic and weights resistance regimens.
High risk occupation was determined by the categoriz-
ation of the 22 possible responses from the COS History
Questionnaire. The presence of OA at one site may be a
risk factor for the development of OA at another site.
Therefore, the presence of OA (grades 2+) at any of the
other three sites was also included as a co-variate in the
adjusted analyses.
Data entries were double-checked by an independent
reviewer. During 1998, the inter-observer variability of
X-ray interpretations was calculated using the kappa
coefficient, measuring the amount of agreement between
one reading and another that is above random chance9.
The significance of the association between smoking status
and the dichotomous outcome of OA was initially assessed
using the Mantel–Haenszel chi-square test statistic10.
Putative confounders for each association were identified
and considered in the adjusted analyses. A factor was
considered a confounder if it was associated with OA
(outcome) and was differentially distributed between
smokers (exposed) and non-smokers (non-exposed). The
Student’s t-test was the statistic employed for determining
statistically significant differences between the continuous
variables age and BMI11. As the study participants had
been observed for unequal lengths of time and some
observations were censored, proportional hazards regres-
sion (Cox’s) was employed12,13 to quantify the relationship
between smoking and OA while simultaneously controlling
for the influence of exogenous factors. The period of
observation was the interval between study entry time
and either: (1) the development of the outcome; (2) study
withdraw; or (3) censoring. The exponentiated beta
coefficients were used to calculate the point estimates
(hazard ratios) for the final predictive models. Statistical
Analyses Software (SAS), Version 8.1214 was employed,
specifically PROC PHREG, for the computer analysis of
these data. Continuous co-variates in the analytic analyses
(age and BMI) were kept as continuous variables. It should
be noted that the results reported for the unadjusted
analyses also used Cox’s regression, with smoking as the
only independent variable in the model. All point estimates
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Evaluation of potential confounders and distribution of current
smoking status by selected factors
Smokers
(N=265)
Never smokers
(N=1198)
Age (mean)* 56.9 61.1
Female (%) 70.9 75.4
Mean BMI at entry 25.3 26.3
Mean BMI at age 45 23.6 24.2
Diabetes (%) 9.8 7.4
Knee injury (%) 1.1 1.6
Heredity (%)* 47.9 55.6
High risk occupation* 19.2 14.3
Physically active** 53.6 65.9
*P-value <0.05; **P-value <0.001.
The P-value notes the statistical significance of the association
between current smoking status and the selected factors listed in
the left column.Table II
Number of incident OA cases in knee, hand, foot, and spine
Knee Hand Foot Spine
Number of subjects free of OA at study entry 2212 1531 2106 1962
Number of incident cases, grades 2+ (%) 708 (32.0) 748 (48.9) 579 (27.5) 1011 (51.5)
Number of incident cases, grades 3+ (%) 205 (9.3) 265 (17.3) 101 (4.8) 309 (15.8)Results
Inter-observer variability by a second radiologist was
high (93% agreement; kappa=0.85). Descriptive analyses
revealed 11% of the study subjects were classified as
current smokers. Efforts were made to identify those factors
known to be associated with OA that were also differentially
distributed by the factor of interest, smoking. Individuals
who were free from OA in at least one site (knee, hand,
foot, or cervical spine) were summarized with respect to
their smoking behavior (N=2505). Stratified analyses noted
that smokers were: (1) younger, (2) had a lower BMI at
study entry and at age 45 years, (3) displayed a higher
percentage of diabetes, (4) experienced a lower percent-
age of knee injury history, (5) had a lower heredity link with
OA, (6) more likely to report a high risk occupation, and (7)
less physically active (Table I). Additionally, statistically
significant differences in age, heredity link, high risk occu-
pation, and physical activity level were demonstrated
between smokers and non-smokers. Next, the examination
of the above factors’ distribution between smoking groups
was conducted separately for all four sites examined knee,
hand, foot, and cervical spine (tables not shown). As the
result of the evaluation for confounding in examining
smoking and OA, age, BMI, gender, heredity, high risk
occupation, physical activity, and OA status (yes/no) at any
of the other three sites were considered in the adjusted
analyses. These descriptive analyses indicated a similar
distribution of factors by smoking behavior for all four
sites. Table II displays the numbers and percentages ofindividuals that became incident cases of OA (site-specific)
during the study period. Percentages ranged from a low of
27.5 % (foot) to a high of 51.5% (cervical spine). The
percentage of participants that became incident cases of
severe OA ranged from a low of 4.8% (foot) and a high of
17.3% (hand).
Evaluations of losses to follow-up were examined for
each site: knee, hand, foot, and cervical spine (Table III).
During the study period, 29–35% of the cohort was con-
sidered lost to follow-up at the time the data were censored
for this study. Differences between those subjects that
were lost to follow-up and those that were not lost were
examined by smoking status. The number of person-years
of follow-up differed by smoking status, as only 11% of
our participants were current smokers. Overall, reasons
for becoming lost to follow-up (death, relocation, or
withdrawal) were fairly similar between our smokers and
non-smokers.
Initially, we looked at the association between smoking
and OA with smoking summarized as ever/never. The point
estimates, ranging from 0.91–1.12 (all non-significant)
approached the null value in many of the sites for both OA
(2+) and severe OA (3+). This method of quantifying an
individual’s smoking history, as well as the former/never
approach, proved to yield little predictive ability for both OA
and severe OA (Tables IV and V). The third approach for
summarizing an individual’s smoking behavior, current/
never, was analysed for an association with OA and severe
OA. Unadjusted analyses for all four sites examined
demonstrated current smoking to have a statistically signifi-
cant protective effect against OA (Table VI). Those indi-
viduals classified as current smokers were 38% less likely
to develop knee OA than were those who were never
smokers (risk ratio=0.62; CI 0.46–0.83). A closely similar
inverse relationship between smoking and OA was demon-
strated for the following sites: hand (risk ratio=0.71;
CI 0.54–0.92), foot (risk ratio=0.63; CI 0.46–0.87), and
cervical spine (risk ratio=0.69; CI 0.54–0.88). We also
investigated the effect current smoking may have with
severe OA (Table VI). A greater protective effect was shown
for severe hand OA relative to hand OA (grades 2+).
After adjusting for the influence of age, gender, BMI,
heredity, occupation, physical activity level and OA status
at other sites, risk estimates for OA and severe OA
spanned both sides of the null value, ranging from 0.60 to
1.48 (Table VII). However, none showed significance in the
relationship between current smoking and OA (or severe
OA) at any of the four sites examined. While gender has
been identified as an important factor in the epidemiology
of OA, we assessed the possible role that gender may play
in the smoking–OA relationship. Interaction terms evaluat-
ing such (smoking×gender) were calculated for all four
sites, for both OA and severe OA. With the exception of
severe knee OA (P=0.03), all corresponding P-values were
non-significant, ranging from 0.17–0.80.
The dose–response relationship was analysed originally
by categorizing the number of cigarettes smoked per dayreported within are hazard ratios. Power calculations
appropriate for time-to-survival study designs were con-
ducted to determine sufficiency of sample size for detecting
an association between smoking and OA15,16. This study
had over 90% power to detect an association of 3.0 or
higher, if indeed, one existed (=0.05).
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Osteoarthritis and Cartilage, Vol. 11, No. 1 33as: 1–19, 20–39, and 40+. Resulting values, notably
smokers who developed OA, were too small for a mean-
ingful analysis, necessitating the collapsing of the latter two
categories (20+/day). The dosage data, available only from
those participants completing four or more histories,
afforded the ability to examine unadjusted OA. Although allpoint estimates were non-significant, the risk estimates
among heavy smokers were lower (more protective) than
those among light smokers at all four sites examined
(Table VIII). However, none of the four sites displayed
significance for a trend in the dose–response relationship.Table IV
Unadjusted association between smoking and OA (and severe
OA) in knee, hand, foot, and spine (ever vs never)
Grades 2+ Grades 3+
RR CI RR CI
Knee 1.01 0.87–1.17 1.09 0.83–1.43
Hand 1.04 0.90–1.20 0.91 0.72–1.16
Foot 0.96 0.82–1.13 1.12 0.75–1.65
Spine 1.07 0.94–1.21 0.94 0.75–1.18
RR=hazard risk ratio; CI=95% confidence interval.Table V
Unadjusted association between smoking and OA (and severe
OA) in knee, hand, foot, and spine (former vs never)
Grades 2+ Grades 3+
RR CI RR CI
Knee 1.12 0.96–1.31 1.24 0.93–1.64
Hand 1.14 0.98–1.33 1.07 0.84–1.38
Foot 1.06 0.89–1.25 1.16 0.77–1.75
Spine 1.18 1.04–1.35 1.01 0.80–1.28
RR=hazard risk ratio; CI=95% confidence interval.Table VI
Unadjusted association between smoking and OA (and severe
OA) in knee, hand, foot, and spine (current vs never)
Grades 2+ Grades 3+
RR CI RR CI
Knee 0.62* 0.46–0.83 0.58 0.32–1.04
Hand 0.71* 0.54–0.92 0.38* 0.22–0.67
Foot 0.63* 0.46–0.87 0.95 0.48–1.89
Spine 0.69* 0.54–0.88 0.67 0.43–1.04
*P-value<0.05.
RR=hazard risk ratio; CI=95% confidence interval.Table VII
Adjusted association between smoking and OA (and severe OA)*
in knee, hand, foot, and spine (current vs never)
Grades 2+ Grades 3+
RR CI RR CI
Knee 0.97 0.71–1.31 1.08 0.58–2.00
Hand 0.99 0.75–1.31 0.60 0.33–1.08
Foot 1.16 0.83–1.63 1.48 0.71–3.08
Spine 0.86 0.67–1.11 0.84 0.53–1.32
*Adjusted for age, body mass index, gender, heredity, occu-
pation, physical activity level, and presence of OA at any of the
other three sites.
RR=hazard risk ratio; CI=95% confidence interval.Discussion
This study explored the association between smoking
and its possible influence on incident OA at four different
sites: knee, hand, foot, and cervical spine. This investi-
gation produced adjusted point estimates suggestive of no
association between smoking and OA. As additional
research is conducted in the field of OA, it is important to
have a commensurate increase in the understanding of
which factors may play an influential role in predicting those
who develop the disease and those who do not. If the
current study had presented smoking to be strongly
associated with OA, albeit inversely, then subsequent OA
research would lend a greater level of concern to the ability
to control for smoking status.
A central concern that was particularly germane for this
epidemiological investigation was the ascertainment of
smoking exposure. The basis on which a given individual
should be considered exposed was carefully considered.
The decision involved defining the measurement of an
individual’s smoking exposure history that was relevant to
the etiology of OA. Such a decision relies heavily on the
understanding of the OA disease process, as well as any
purported induction period involved. Clearly the current
level of understanding of the etiology of OA, or lack
thereof, has placed limits on the ability to do such. For
example, when evaluating the relationship that smoking
shares with lung cancer, the total duration and dose of
smoking is considered etiologically important. However,
when examining smoking and its influence on myocardial
infarction, the current smoking behavior is the most
relevant exposure17. Due to the paucity of smoking-OA
studies, the most appropriate time window for the evalu-
ation of smoking and its potential influence on OA is
unclear. From our analyses, it is apparent the smoking
exposure classification of ever/never utilizes information
spanning too wide a period. This categorization scheme
classifies individuals as smokers even if they had only a
brief exposure early in life. In terms of teasing out the role
smoking may play in OA, casting such a wide net did not
afford the ability to make any valid inferences on the
relationship. Given the dearth of OA studies examining
smoking relative to other putative factors, our approach
was to evaluate the data from various time windows of
smoking exposure to gain information about the period
that appears most relevant to OA.
Our findings do not confirm many results from previously
published point estimates quantifying this relationship. The
Framingham Osteoarthritis Study (FOS) noted an adjusted
estimate of 0.78 (P-value <0.05) for knee OA. Controlling
for the same factors of age, gender, and BMI, the current
COS study indicated a knee OA point estimate, 0.83
(P-value >0.05, data not shown). It should be noted that the
FOS exposure variable was smoking status at examination
1, while the OA assessment was subsequently conducted
approximately 20 years later during the 18th examination.
Information was unavailable to determine whether smoking
status at the first visit continued at the same rate until
radiological assessment of the knee at the 18th visit.
Alternatively, the present study utilized current smoking
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Unadjusted association between smoking and OA (grades 2+) by dose* in knee, hand, foot, and spine (current
vs never)
Knee Hand Foot Spine
RR CI RR CI RR CI RR CI
Never smokers 1.00 — 1.00 — 1.00 — 1.00 —
1–19/day 0.20 0.03–1.44 1.21 0.47–3.08 1.02 0.37–2.86 0.78 0.42–1.44
20+/day 0.15 0.02–1.10 0.81 0.29–2.27 0.18 0.02–1.29 0.67 0.37–1.22
*Average number of cigarettes smoked per day.
RR=hazard risk ratio; CI=95% confidence interval.status queried prior to the OA diagnosis. Our results
suggest a less protective effect by smoking for severe knee
OA compared with the FOS findings (RR=0.82; P-value
>0.05 and OR=0.71; P-value <0.05, respectively). The
aforementioned estimates were adjusted for age, sex, and
weight. The disparity in the point estimates between the
COS and FOS data may be partially attributable to the
aforementioned differences in the timing of exposure
assessment. A portion of the difference may be explained
by the current study’s capability to exclude prevalent dis-
ease, thus considering only incident cases. The discrep-
ancy cannot be explained by methods in X-ray attainment
(for knee both used anteroposterior, weight-bearing), nor
most likely by social class. COS and FOS study samples
drew upon a predominantly white, middle-class population.
In concurrence with our unadjusted dose–response find-
ings, four of the five previously published studies examining
the smoking–OA relationship3–6 reported results confirming
or suggesting a dose response.
This study has added to the body of OA literature through
its contribution in four areas.
(1) Previous studies reporting results for this relationship
were analysed using either cross-sectional or case-control
epidemiological designs. The current prospective study has
served to generate point estimates that benefit from the
enhanced power of the cohort design. Prevalent OA cases
at study entry were excluded from our analyses, allowing
the ability to clearly establish the temporal relationship
between smoking behavior (exposure) and subsequent OA
(outcome). Previous studies have been unable to firmly
establish the timing sequence between smoking and OA.
For example, in previously published studies if an indi-
vidual developed OA, then subsequently ceased smoking
(possibly due to seeking a healthier life-style since
developing OA), an investigator would not be able to
discern which came first: the smoke-free behavior or the
development of OA. This particular scenario would serve to
artificially elevate the association between non-smokers
and OA. The ability of the current study to make such a
temporal distinction has afforded a clearer view of the
smoking–OA relationship.
(2) Additionally, this study has provided an initial glimpse
at the role smoking may play in OA of the foot and
cervical spine. The venerable National Health and Nutrition
Examination Survey6, the Framingham Osteoarthritis
Study3, as well as the 1999 study by Sandmark et al.5
added valuable insight to the smoking–knee OA relation-
ship. The 1993 Chingford Study reported results for both
the knee and the hand4. A review of the literature indicate
that this is the first study to examine the smoking–OA
relationship for the foot or cervical spine. In terms
of ultimately determining causality, the ability to quantifythe relationship at various sites will allow an increased
understanding of what mechanisms may, or may not, be at
play.
(3) This prospective study utilized a sample (N=2505)
that was 77% larger than samples previously analysed for
evaluating this association. If smoking, in reality, shares
a very modest association with OA, it would take a
substantial-sized sample to have the statistical power to
detect such a relationship. (4) Lastly, this study has con-
tributed by quantifying point estimates for the smoking–OA
relationship for the knee and hand, thus providing a basis of
comparison with previously published results in other
investigations.
In evaluating these study results, it is important to
consider whether study participants with any OA-risk factor
combination (e.g. has OA and a history of smoking) were
more or less likely to be selected than were others. One
venue in which this type of selection bias can occur is when
study recruits are aware of the details of the hypotheses
under investigation. This is unlikely to have occurred for the
Clearwater Osteoarthritis Study. Prospective participants
were informed this would be a large-scale, longitudinal
study attempting to identify various factors that may play a
role in the development and progression of OA. However,
participants were blinded as to the details regarding the
hypotheses to be tested, including which specific risk
factors were to be examined. The etiology of OA is largely
an enigma among the scientific community. It can be
assumed that the general public may have even less
insight as to the factors that may be associated with OA,
hence minimizing the likelihood of this form of selection
bias.
It should be noted that the four primary hypotheses
evaluated smoking and its relationship with knee, hand,
foot, and cervical spine. A conventional level of alpha of
0.05 was selected a priori for the determination of the
statistical significance of the resulting point estimate. The
reader should be reminded that a significance level is a
function of, among other factors, the number of hypotheses
under investigation. If four separate analyses are con-
ducted for each site (knee, hand, foot, and cervical
spine), the probability of one or more significant results
is 0.20 (4×0.05), under alpha=0.05. As suggested by
Bonferroni18, appropriate compensation for multiple com-
parisons is to decrease the alpha level by dividing it by the
number of hypotheses studied. Thus, if we consider (four
sites)×(two types of OA: 2+ and 3+), we reduce our
acceptance level for any given hypothesis test precipitously
to alpha=0.006. This is not an inherent limitation to this
specific study, or to numerous other similarly conducted
studies, but rather a fair caution to the reader to interpret
these findings in a conservative, suitable manner. As this
Osteoarthritis and Cartilage, Vol. 11, No. 1 35study evaluates smoking as the primary exposure, compet-
ing causes of mortality were considered as a phenomenon
possibly influencing the results. To introduce bias into these
findings, the death rate of smokers with OA would need to
be significantly different than the death rate of smokers
without OA. The death rate among smokers with OA (4.7%)
was lower than the death rate among smokers without OA
(6.9%). However, it is suggested that this difference would
not strongly influence the findings from this study.
No clear biologic explanation supports an inverse re-
lationship between smoking and OA. However, theories
have suggested that smoking may affect the cartilage
directly, or when considering knee OA, it may act in an
indirect manner by conveying protection through making
the subchondral bone more deformable to impact loads19.
Subsequent epidemiological studies employing the power
of the cohort design will complement the results of this
study. While these findings corroborate previous studies
indicating no association between smoking and OA, anec-
dotal evidence warrants investigation into the role that
cigarette smoking may play in the symptomatology of OA.
Future research focusing on the inverse relationship
between OA and osteoporosis (known to be positively
associated with smoking) may serve to enhance our under-
standing of the mechanisms affecting the etiology of OA.References
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